CMIC：2019年在药物开发新时代中定制生物分析测试报告（英文版）

All of this again favors strategic partnerships with specialist service providers, basedless on size than on flexible and responsive expertise. “Client needs are changing inthat respect," Suga comments.“Our clients tend to be relatively entrepreneurial, moremiddle-sized biotech companies, with diversified customer requirements.”As a medium-sized CRO, “we hear a lot of customers complaining that the huge CROsare not addressing their needs", he continues. “When the sponsor is middle-s